"It does appear to indicate a point of disagreement which led to the changes to Board and Management."
If there was a sharp point of disagreement, could it have been in relation to a deal that was already on the table? Remember Phylogica did spend $1.5m in consultants fees although the stated reason for the consultancy was a review of corporate strategy resulting in the Pivot to Platform strategy. Further, the appointment of Michael Williams as NED was heralded with the notation that Williams brought significant experience 'at an important time in the commercialisation of Phylogica's unique platform technology and engagement with potential partners' refer Operational Update December quarter.
Pushing on with the diversification and acceleration of development would undoubtedly deliver more data and would arguably add greater value to shareholders in the event of a future sale. Just speculation as there are numerous reasons which could explain the Board and Management changes - its the $8m question.
- Forums
- ASX - By Stock
- PYC
- Ann: Changes to Board and Management
Ann: Changes to Board and Management, page-44
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.020(11.1%) |
Mkt cap ! $933.2M |
Open | High | Low | Value | Volume |
18.0¢ | 20.5¢ | 18.0¢ | $1.219M | 6.294M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 106194 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 184767 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.195 |
4 | 106766 | 0.190 |
5 | 176660 | 0.180 |
5 | 141210 | 0.175 |
8 | 614286 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 184767 | 1 |
0.205 | 1120723 | 7 |
0.210 | 995000 | 3 |
0.215 | 1098416 | 5 |
0.220 | 1002000 | 3 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |